European Heart Journal vs Gastroenterology: Which Journal Should You Choose?
European Heart Journal is the better first target for broad cardiovascular papers. Gastroenterology is stronger for flagship GI work that still lives inside digestive disease.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
European Heart Journal vs Gastroenterology: Which Journal Should You Choose at a glance
Use the table to get the core tradeoff first. Then read the longer page for the decision logic and the practical submission implications.
Question | European Heart Journal | Gastroenterology: Which Journal Should You Choose |
|---|---|---|
Best when | You need the strengths this route is built for. | You need the strengths this route is built for. |
Main risk | Choosing it for prestige or convenience rather than real fit. | Choosing it for prestige or convenience rather than real fit. |
Use this page for | Clarifying the decision before you commit. | Clarifying the decision before you commit. |
Next step | Read the detailed tradeoffs below. | Read the detailed tradeoffs below. |
Most papers will never face this decision. When they do, the decision is usually about audience, not prestige.
If the manuscript should change how cardiologists think or practice, European Heart Journal is usually the better first target. If the paper should change how gastroenterologists or hepatologists think or practice, Gastroenterology is usually the better first target.
That may sound simple, but crossover work can blur the line. Cardiometabolic disease, liver-cardiovascular overlap, microbiome and vascular risk, obesity-related cardiovascular studies, and therapy-safety papers can often be framed in either direction. That's where authors get stuck.
Quick verdict
European Heart Journal is for top cardiovascular papers with broad field consequence. Gastroenterology is for top digestive-disease papers that may be mechanistic, translational, or clinically important, but still belong inside GI.
The mistake is to decide by impact factor or by which title looks more famous. The better rule is to ask: which readership has to understand this paper first for it to matter?
Head-to-head comparison
Metric | European Heart Journal | Gastroenterology |
|---|---|---|
2024 JIF | 35.6 | 25.1 |
Quartile | Q1 | Q1 |
Estimated acceptance rate | Around 10% | Around 12% |
Estimated desk rejection | Very high for narrow or non-cardiology framing | High for work without clear field-level GI significance |
Typical first decision | Quick editorial triage, then full review for selected papers | Fast editorial filtering, then specialty review |
Publisher / ecosystem | Oxford Academic / ESC | Elsevier / AGA ecosystem |
Strongest fit | Field-level cardiovascular consequence | Flagship digestive-disease papers, including mechanistic and liver work |
The main editorial difference
EHJ wants cardiovascular breadth. Gastroenterology wants digestive-disease depth plus field-level importance.
That difference matters because some crossover papers look large enough for a flagship journal in either field, but only one field actually needs the message as a first-order result.
EHJ's editorial guidance keep emphasizing general cardiology relevance, methodological rigor, and ESC-facing importance. Gastroenterology comparison's editorial guidance emphasize mechanistic GI work, liver and motility strength, and a willingness to carry more field-specific narrative than Gut or a general-medicine journal would.
So if your paper needs GI architecture to be convincing, Gastroenterology is often the better call. If it becomes stronger when converted into general cardiovascular language, EHJ is more plausible.
Where European Heart Journal wins
EHJ wins when the manuscript is fundamentally a cardiovascular paper.
That usually means:
- the primary outcome is cardiovascular
- the clinical implication is about cardiology management, risk, or prevention
- cardiologists are the natural first readers
- the digestive-disease context matters, but the cardiovascular consequence is the real headline
Examples:
- cardiovascular-risk studies in metabolic or inflammatory conditions when the message is for cardiology practice
- vascular-outcomes work where digestive-disease context is important, but not the central readership
- therapy-safety or risk-prediction papers that should influence broad cardiovascular interpretation
Where Gastroenterology wins
Gastroenterology wins when the paper is still best understood as a GI or hepatology paper.
That includes:
- digestive-disease studies with strong translational or mechanistic value
- liver and motility work that needs more field-specific narrative
- microbiome and inflammatory-disease papers that remain clearly GI-led
- clinical GI studies whose most important readers are still gastroenterologists
The practical point is that Gastroenterology can be the correct first target even for very ambitious papers if the field-specific audience is still the right one.
Specific journal facts that matter
EHJ strongly filters on breadth
EHJ submission's editorial guidance makes clear that narrow, single-center, or limited-consequence work gets screened out early. That's relevant for organ-overlap papers because they can look important inside one specialty but still not broad enough for a flagship general cardiology journal.
Gastroenterology gives more room to complex GI stories
comparison's editorial guidance already used in this branch notes that Gastroenterology is often more tolerant of longer mechanistic or layered narratives than Gut. That matters for crossover papers where the biology, digestive-disease framing, or liver context can't be compressed without weakening the paper.
EHJ expects a clearer argument for cardiovascular practice
The journal wants authors to explain how the work matters to cardiologists, often with explicit practice or guideline relevance. If that argument feels forced, the paper usually belongs somewhere else.
Gastroenterology still demands consequence, not just specialty fit
Being GI-shaped isn't enough. The paper still has to look like a flagship digestive-disease paper with enough importance to matter across the field.
Choose European Heart Journal if
- the paper is fundamentally cardiovascular
- general cardiologists are the primary readers
- the main result is about cardiovascular outcomes, risk, or treatment
- you can explain the paper's significance without depending on GI-specific context
That's the EHJ lane.
Choose Gastroenterology if
- the paper is fundamentally about digestive disease or liver disease
- GI specialists are the primary readers
- the paper needs GI-specific context to show why it matters
- the manuscript gets stronger, not weaker, when written for a specialty audience
That's the Gastroenterology lane.
Which papers create the hardest split
Microbiome and cardiometabolic papers
If the study is mostly about microbiome biology or digestive-disease mechanisms, Gastroenterology is usually more natural. If the paper is really about cardiovascular risk prediction or management, EHJ becomes more realistic.
Liver disease and cardiovascular outcomes
This can go either way. The real question is whether the message changes cardiology behavior or primarily helps hepatologists and GI clinicians interpret liver-related cardiovascular risk.
Obesity and metabolic disease overlap
Some obesity and metabolic papers can look broad enough for cardiology if the cardiovascular endpoint is strong and central. Others are still much more coherent as GI or hepatology papers if the metabolic and digestive-disease logic drives the story.
The cascade strategy
This is a reasonable but selective cascade.
A paper rejected by EHJ can move to Gastroenterology if:
- the work is genuinely GI-led
- the rejection reflects breadth rather than quality
- the paper still looks strong enough for a flagship GI journal
The opposite route is less common. A paper rejected by Gastroenterology because it isn't GI-defined enough doesn't often improve by moving to EHJ unless the cardiovascular consequence was actually underemphasized from the start.
What each journal is quick to punish
EHJ punishes specialty dependence
If the whole argument depends on the reader already caring about digestive disease, liver disease, or microbiome biology, EHJ gets much harder.
Gastroenterology punishes weak field consequence
The journal can carry field-specific papers, but they still have to look important. A narrow GI study with weak top-line consequence will still struggle.
EHJ punishes inflated generality
One recurring problem with crossover work is pretending that a specialty result is a field-wide cardiovascular event. EHJ editors are unlikely to reward that mismatch.
Gastroenterology punishes vague translational claims
If the manuscript sounds "translational" but can't show a concrete clinical or mechanistic payoff, the story weakens quickly.
What a strong first page looks like in each journal
A strong EHJ first page tells a cardiology editor why this changes cardiovascular interpretation, care, or risk thinking right away.
A strong Gastroenterology first page tells a GI editor why this changes digestive-disease understanding, translational logic, or specialty practice right away.
If you can only make one of those first pages feel clean, that's usually your answer.
Another practical clue
Try these finishing lines:
- "this changes how cardiologists interpret risk or treatment" points toward European Heart Journal
- "this changes how gastroenterologists or hepatologists interpret disease or treatment" points toward Gastroenterology
That sentence test is blunt, but it's often the fastest honest triage tool.
A realistic decision framework
Send to European Heart Journal first if:
- the manuscript is fundamentally cardiovascular
- general cardiology is the natural audience
- broad cardiovascular consequence is the main reason the paper matters
- the digestive-disease context supports, but doesn't define, the message
Send to Gastroenterology first if:
- the manuscript is fundamentally GI or liver focused
- digestive-disease specialists are the natural audience
- the paper needs specialty framing to be maximally convincing
- the field-specific narrative is a strength, not a weakness
Bottom line
Choose European Heart Journal for crossover papers whose real consequence sits in cardiovascular medicine and whose natural readership is general cardiology. Choose Gastroenterology for crossover papers whose real consequence still sits inside digestive disease, hepatology, or mechanistic GI science.
That's usually the smarter first submission strategy, and it won't get clearer by pretending a crossover paper belongs equally to both fields.
If you want a fast outside read on whether your paper is actually broad cardiology or still a flagship GI paper, a free Manusights scan is a useful first filter.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.